$746 Million is the total value of Boussard & Gavaudan Investment Management LLP's 27 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was - . Boussard & Gavaudan Investment Management LLP is a registered-investment adviser.
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGN | New | ALLERGAN PLC | $219,436,000 | – | 1,301,903 | +100.0% | 29.40% | – |
LBTYK | New | LIBERTY GLOBAL PLC | $9,377,000 | – | 329,822 | +100.0% | 1.26% | – |
SSPKU | New | SILVER SPIKE ACQUISITION CORunit | $9,080,000 | – | 900,000 | +100.0% | 1.22% | – |
EXPCU | New | EXPERIENCE INVESTMENT CORPunit | $9,000,000 | – | 900,000 | +100.0% | 1.21% | – |
THBRU | New | THUNDER BRDG ACQUISITION Lunit | $8,160,000 | – | 800,000 | +100.0% | 1.09% | – |
MSGN | New | MSG NETWORK INCcl a | $6,544,000 | – | 287,028 | +100.0% | 0.88% | – |
SCPEU | New | SC HEALTH CORPunit | $6,210,000 | – | 600,000 | +100.0% | 0.83% | – |
OACU | New | OAKTREE ACQUISITION CORPunit | $4,068,000 | – | 400,000 | +100.0% | 0.54% | – |
NPAUU | New | NEW PROVIDENCE ACQUISITIN COunit | $3,018,000 | – | 300,000 | +100.0% | 0.40% | – |
TGE | New | TALLGRASS ENERGY LP | $1,860,000 | – | 92,940 | +100.0% | 0.25% | – |
SRPT | New | SAREPTA THERAPEUTICS INC | $1,721,000 | – | 23,173 | +100.0% | 0.23% | – |
CPAAU | New | CONYERS PK II ACQUISITION COunit | $1,599,000 | – | 150,000 | +100.0% | 0.21% | – |
L100PS | New | ARCONIC INC | $1,211,000 | – | 46,483 | +100.0% | 0.16% | – |
BLUE | New | BLUEBIRD BIO INC | $1,054,000 | – | 11,591 | +100.0% | 0.14% | – |
LBTYA | New | LIBERTY GLOBAL PLC | $854,000 | – | 34,484 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-22
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ALIBABA GROUP HLDG LTD | 20 | Q1 2022 | 93.8% |
CRITEO S A | 16 | Q2 2018 | 22.5% |
LIBERTY BROADBAND CORP | 15 | Q3 2023 | 5.3% |
TIM PARTICIPACOES S A | 14 | Q2 2018 | 46.5% |
TIFFANY & CO NEW | 14 | Q3 2020 | 11.0% |
AMBAC FINL GROUP INC | 14 | Q3 2023 | 2.4% |
CONSTELLIUM SE | 14 | Q3 2019 | 5.7% |
CONSTELLIUM SE | 13 | Q4 2022 | 12.4% |
ASHLAND INC | 12 | Q2 2023 | 5.9% |
MEAD JOHNSON NUTRITION CO | 11 | Q1 2017 | 36.9% |
View Boussard & Gavaudan Investment Management LLP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-10 |
13F-HR | 2022-05-12 |
13F-HR/A | 2022-02-15 |
13F-HR | 2022-02-10 |
View Boussard & Gavaudan Investment Management LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.